Literature DB >> 3773907

Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis.

J Björkander, U Bengtsson, V A Oxelius, L A Hanson.   

Abstract

Several patients with subnormal levels of IgG subclasses have repeated infections. Further controlled studies are required to better define the relation between the level of the various subclasses and the possible clinical consequences. It may be important to determine whether or not IgG subclass deficiency can lead to infections which cause lung damage as was suggested in a few patients with IgA deficiency combined with low IgG subclass levels. An open study of the effect of immunoglobulin prophylaxis in 38 patients with subnormal levels of one or two of the IgG subclasses 1, 2 or 3 during altogether 1,524 months of observation suggested that many of them improved. This must be further substantiated in carefully controlled studies. Immunoglobulin prophylaxis could be given in IgG subclass deficient patients with IgA deficiency and anti-IgA antibodies, provided a preparation poor in IgA was used and the patients' anti-IgA titres did not increase during the prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3773907

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN: 0077-0760


  10 in total

Review 1.  The heterogeneity of IgA deficiency.

Authors:  L A Hanson; J Björkander; B Carlsson; D Roberton; T Söderström
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

2.  Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy.

Authors:  F Abrahamian; S Agrawal; S Gupta
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

3.  Antibody response to the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in healthy and infection-prone individuals with IgG3 subclass deficiency.

Authors:  M Hahn-Zoric; M Ulanova; V Friman; J Björkander; V A Oxelius; A Lucas; L A Hanson
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

4.  Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies.

Authors:  C Cunningham-Rundles; Z Zhou; S Mankarious; S Courter
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

5.  Isotype distribution of mucosal IgG-producing cells in patients with various IgG subclass deficiencies.

Authors:  D E Nilssen; R Söderström; P Brandtzaeg; K Kett; L Helgeland; G Karlsson; T Söderström; L A Hanson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

6.  Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.

Authors:  D E Nilssen; P Brandtzaeg; S S Frøland; O Fausa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 7.  The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases.

Authors:  Suqing Zhou; Qianwen Li; Haijing Wu; Qianjin Lu
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 11.530

8.  An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens.

Authors:  Vladimíra Fejfarová; Alexandra Jirkovská; Michal Dubský; Frances Game; Jana Vydláková; Alena Sekerková; Jana Franeková; Monika Kučerová; Ilja Stříž; Vladimír Petkov; Robert Bém; Veronika Wosková; Andrea Němcová; Jelena Skibová
Journal:  J Diabetes Res       Date:  2016-12-05       Impact factor: 4.011

9.  Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections.

Authors:  Diana A van Kessel; Thijs W Hoffman; Heleen van Velzen-Blad; Pieter Zanen; Jan C Grutters; Ger T Rijkers
Journal:  EBioMedicine       Date:  2017-03-21       Impact factor: 8.143

10.  Factors associated with IgG levels in adults with IgG subclass deficiency.

Authors:  James C Barton; Jackson Clayborn Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Immunol       Date:  2021-08-09       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.